Published guidance, NICE advice and quality standards | Guidance

Showing 801 to 810 of 2013

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Pembrolizumab for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (terminated appraisal)	TA674	17 February 2021	17 February 2021
Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal)	TA675	17 February 2021	17 February 2021
Trabectedin for the treatment of advanced soft tissue sarcoma	TA185	24 February 2010	8 February 2021
Mepolizumab for treating severe eosinophilic asthma	TA671	3 February 2021	3 February 2021
Brolucizumab for treating wet age-related macular degeneration	TA672	3 February 2021	3 February 2021
Leukomed Sorbact for preventing surgical site infection	HTG567	3 February 2021	3 February 2021
Brain tumours (primary) and brain metastases in over 16s	NG99	11 July 2018	29 January 2021
Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor	TA670	27 January 2021	27 January 2021
The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to heal	HTG566	27 January 2021	27 January 2021
Self-expanding implant insertion into the intersphincteric space for faecal incontinence	HTG564	27 January 2021	27 January 2021